VANCOUVER, BC / ACCESS Newswire / January 13, 2026 / Star Copper Corp. (CSE:STCU)(OTCQX:STCUF)(FWB:SOP) ("Star Copper" or the "Company"), a critical minerals exploration and development company, is ...
(RTTNews) - Crinetics Pharmaceuticals Inc. (CRNX) has dosed the first patient in its Phase 2/3 trial of investigational drug Atumelnant for the treatment of classic congenital adrenal hyperplasia in ...
– Olezarsen met the primary endpoint with statistically significant reduction of fasting triglycerides and showed substantial, clinically meaningful reduction in acute pancreatitis events – – Results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results